Vicarious Surgical (RBOT) Change in Acquisitions & Divestments (2023 - 2025)
Vicarious Surgical's (RBOT) quarterly Change in Acquisitions & Divestments came in at $13.8 million in Q3 2025, up 2.9% year-on-year from $13.4 million in Q3 2024, and down 18.6% on a QoQ basis from $16.9 million in Q2 2025.
Vicarious Surgical (RBOT) Change in Acquisitions & Divestments (2023 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $13.8 million in Q3 2025.
- On a quarterly basis, Change in Acquisitions & Divestments rose 2.9% year-over-year to $13.8 million in Q3 2025; TTM through Sep 2025 was $64.2 million, a 0.03% change from a year earlier, with the FY2024 full-year figure at $65.2 million, up 106.36% from the prior year.
- Change in Acquisitions & Divestments for Q3 2025 stood at $13.8 million, down from $16.9 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for RBOT reached as high as $20.0 million in Q4 2024 and fell as low as $12.5 million in Q2 2024.
- Historically, Change in Acquisitions & Divestments has averaged $16.1 million across 3 years, with a median of $15.3 million in 2025.
- On a YoY basis, Change in Acquisitions & Divestments climbed as much as 35.71% in 2025 and fell as far as 30.01% in 2025.
- Year by year, Change in Acquisitions & Divestments stood at $19.1 million in 2023, then advanced by 5.01% to $20.0 million in 2024, then tumbled by 31.25% to $13.8 million in 2025.
- Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $13.8 million in Q3 2025, $16.9 million in Q2 2025, and $13.6 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.90 Bn | 176.61 Bn | 6.27 Bn |
| 2 | Stryker | 128.85 Bn | 125.97 Bn | 3.81 Bn |
| 3 | Medtronic | 108.77 Bn | 99.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.39 Bn | 66.93 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.50 Bn | 44.83 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.08 Bn | 1.98 Bn |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.35 Bn | 2.07 Bn |
| 10 | Vicarious Surgical | 625,212.51 | -9.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 13.76 Mn |
| Sep 30, 2025 | 13.76 Mn |
| Jun 30, 2025 | 16.90 Mn |
| Jun 30, 2025 | 16.90 Mn |
| Mar 31, 2025 | 13.55 Mn |
| Mar 31, 2025 | 13.55 Mn |
| Dec 31, 2024 | 20.01 Mn |
| Dec 31, 2024 | 20.01 Mn |
| Sep 30, 2024 | 13.37 Mn |
| Sep 30, 2024 | 13.37 Mn |
| Jun 30, 2024 | 12.45 Mn |
| Jun 30, 2024 | 12.45 Mn |
| Mar 31, 2024 | 19.36 Mn |
| Mar 31, 2024 | 19.36 Mn |
| Dec 31, 2023 | 19.06 Mn |
| Dec 31, 2023 | 19.06 Mn |